Observational studyMedicine2022

Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus.

Antonio Solana-Altabella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.